Today: 9 June 2026
Robinhood (HOOD) Skyrockets: S&P 500 Entry, Explosive Q2 Results & Bullish Analyst Forecasts
29 September 2025
4 mins read

Robinhood (HOOD) Skyrockets: S&P 500 Entry, Explosive Q2 Results & Bullish Analyst Forecasts

  • Trading Metrics: On Sept 29, 2025 HOOD opened around $121.78, trading in a $120.46–$125.06 range with ~25.7M shares volume . Its market cap is roughly $108.2B, with a 52-week range of ~$22.05–$130.07. The stock has surged about 3× YTD (far above the broader market) . Notably, it briefly hit a new 52-week high (~$130) in mid-September before settling near current levels. HOOD’s 50-day moving average (~$110) and 200-day MA (~$79) are well below the current price, reflecting strong upward momentum.
  • Recent Performance: Year-to-date (Jan–Sept 2025) HOOD has risen ~227% (nearly tripled) reuters.com. For context, Reuters noted in early Sept that the stock had “more than doubled” for the year, giving a market cap of ~$91.5B then reuters.com. The recent run was fueled by robust trading volumes and crypto enthusiasm. In the past week, HOOD has stayed above $120, with most pullbacks testing its ~50-day MA.
  • S&P 500 Inclusion: In a watershed move for fintech, S&P Dow Jones announced on Sept 5 that Robinhood will join the S&P 500 (replacing Caesars) before the open on Sept 22 . This is expected to boost institutional demand (index funds must buy) and signal broader market credibility. The S&P news sent HOOD up ~7% in after-hours trading . (Coinbase became the first crypto firm in the S&P in May 2025 , highlighting the rising legitimacy of fintech/crypto stocks.)
  • Q2 2025 Blowout: On July 30 (after market close), Robinhood reported blockbuster Q2 earnings. Revenue jumped 45% YoY to $989M, and net income doubled to $386M (42¢ EPS) sec.gov reuters.com – easily topping forecasts (~31¢). Transaction-based revenue surged 65% (to $539M), driven by equities +65%, options +46%, and crypto +98% reuters.com. All major metrics hit records: equity volumes ~$517B (+112% YoY), options contracts 515M (+32%), crypto volumes $28B on Robinhood app (+32%) sec.gov (plus $7B on Bitstamp after its acquisition). Active user growth was strong: funded customers hit 26.5M (+10% YoY) sec.gov, and Robinhood Gold premium subscribers reached 3.5M (record; +76% YoY) sec.gov reuters.com. CFO Jason Warnick said customers “lean in and buy” when markets dip, noting momentum carried into July reuters.com. Zacks Research enthused “the retail crowd is back” – customers are now subscribing to Gold, using the new credit card, and adding deposits “like it’s 2021 again” reuters.com.
  • Product & Expansion: Robinhood is aggressively broadening its offerings. In June 2025 it closed acquisition of Bitstamp (major global crypto exchange) and filed to acquire Canada’s WonderFi (expected H2’25 close) sec.gov, deepening its crypto ecosystem. It also expanded crypto in Europe: launching stock tokens on 200+ U.S. stocks and entering ~30 EU countries sec.gov. On Sept 10, at its annual HOOD Summit 2025, Robinhood unveiled “Robinhood Social” (an in-app trading community for sharing verified live trades, a regulated copy-trading feature) along with new AI-driven indicators and futures trading on its Robinhood Legend platform newsroom.aboutrobinhood.com. CEO Vlad Tenev proclaimed that Robinhood is now “no longer just where you trade – it’s your financial superapp” newsroom.aboutrobinhood.com reuters.com. On Sept 15 the firm announced Robinhood Ventures Fund I (RVI) – a closed-end fund to let retail investors buy shares in pre-IPO private companies – filing with the SEC to list RVI on the NYSE newsroom.aboutrobinhood.com.
  • Analyst Sentiment: Wall Street is largely bullish. Analyst consensus (TipRanks) is a “Moderate Buy”: 12 Buy vs 6 Hold ratings, with an average 12-month target ~$127 tipranks.com. MarketBeat data shows analysts have been raising targets (Needham $120, KeyCorp $110, Morgan Stanley $110, Citigroup $135, Cantor $118) marketbeat.com. The consensus price target from MarketBeat is ~$104.06 marketbeat.com (implying modest upside from current levels). Some caution exists: one Seeking Alpha analyst notes HOOD’s fundamentals are strong but valuation “appears overvalued” versus peers like Interactive Brokers and Schwab, suggesting a potential near-term pullback seekingalpha.com. Overall, the mix of booming growth and high multiples is fueling debate among strategists and subscribers.
  • Industry Context: Robinhood’s strength reflects wider fintech and retail-trading trends. Retail investors now account for a sizeable slice of market volume – one study pegs their share at ~8% of total dollar volume (rising to ~16% for blockbuster names) , and another analysis estimates ~20% on heavily traded days . Regulators are also reshaping the scene: notably the SEC closed its probe of Robinhood Crypto in Feb 2025 with no action , and the approval of spot Bitcoin ETFs in Jan 2025 has boosted crypto trading (a boon to Robinhood’s Q1 volumes ). Competitors are pushing similar strategies. Coinbase (COIN) reported Q2 revenue ~$1.5B despite a crypto market slump, and joined the S&P 500 in May 2025 . Traditional brokerages are responding too – for example, Fidelity rolled out an advanced Trader+ platform on Sept 25 to woo active investors with real-time analytics and customizable charts . Fintech lenders (SoFi, Upstart, etc.) and crypto-exchanges (Binance, Kraken) are also expanding their services, reflecting a broader battle for the next-generation investor.
  • Investor Sentiment: Social media buzz around HOOD is high. The stock’s run and S&P news have provoked a flurry of posts on Reddit forums (e.g. r/wallstreetbets) and on StockTwits (which has ~86K followers on HOOD), where users debate its sky-high returns. Robinhood’s own posts on X (Twitter) highlight its new features – CEO Tenev’s “financial super-app” pitch reuters.com has been retweeted widely. Sentiment appears mostly positive post-Q2: retail traders are celebrating the gains, while more skeptical voices warn of a correction given stretched multiples.

In summary, as of Sep 29, 2025 Robinhood (HOOD) is enjoying a major rally underpinned by strong earnings, big user growth, and high-profile expansions (S&P 500 entry, crypto deals, new products). Analysts generally expect continued growth (average targets in the $110–$130 range ), but caution on valuation and competition is mounting. The fintech sector’s surge in retail trading, combined with upcoming Fed rate cuts (which tend to favor growth stocks) and evolving crypto/AI trends, will be key factors to watch. Investors and media outlets continue to cite Robinhood’s own disclosures and analyst reports for guidance; all the above points are supported by recent earnings filings, press releases, and news articles .

Sources: Official Robinhood releases (newsroom, SEC filings) and reputable financial news (Reuters, MarketBeat, TipRanks, etc.) provided the data above . All specific figures and quotes are drawn from these connected sources.

Stock Market Today

  • Soybean Prices Decline Amid Lower Export Shipments and Reduced Speculative Positions
    June 9, 2026, 9:21 AM EDT. Soybean prices fell between 2 and 5 ½ cents on Monday, with the national average cash price dropping to $10.58 3/4 per bushel. Export shipments for the week ending June 4 decreased by 21.2% from the previous week, totaling 398,186 MT, and are down 28.8% year-over-year. Key buyers included Egypt, China, and Mexico. Marketing year exports stand 20.3% lower compared to last year. Meanwhile, speculative traders reduced their net long positions in soybean futures and options by 33,502 contracts, signaling cautious market sentiment. Soymeal and soy oil futures also declined modestly. A private export sale of 264,000 MT was reported for the 2026/27 season, but overall market pressure weighs on prices going into the week.

Latest articles

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
$1B Fusion Lab Headed to Albuquerque — Is Clean Energy on the Horizon?
Previous Story

$1B Fusion Lab Headed to Albuquerque — Is Clean Energy on the Horizon?

Wolfspeed’s Wild Ride: From Bankruptcy Plans to EV Boom – What’s Next for WOLF Stock?
Next Story

Wolfspeed’s Wild Ride: From Bankruptcy Plans to EV Boom – What’s Next for WOLF Stock?

Go toTop